Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5085356
Max Phase: Preclinical
Molecular Formula: C28H30N8O3
Molecular Weight: 526.60
Molecule Type: Unknown
Associated Items:
ID: ALA5085356
Max Phase: Preclinical
Molecular Formula: C28H30N8O3
Molecular Weight: 526.60
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc(-c2nc3c(C(N)=O)cccc3[nH]2)ccc1Nc1ncc2c(n1)N(C1CCCC1)[C@H](C)C(=O)N2C
Standard InChI: InChI=1S/C28H30N8O3/c1-15-27(38)35(2)21-14-30-28(34-26(21)36(15)17-7-4-5-8-17)32-19-12-11-16(13-22(19)39-3)25-31-20-10-6-9-18(24(29)37)23(20)33-25/h6,9-15,17H,4-5,7-8H2,1-3H3,(H2,29,37)(H,31,33)(H,30,32,34)/t15-/m1/s1
Standard InChI Key: AHLUXFFYVNFYEN-OAHLLOKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 526.60 | Molecular Weight (Monoisotopic): 526.2441 | AlogP: 3.98 | #Rotatable Bonds: 6 |
Polar Surface Area: 142.36 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.43 | CX Basic pKa: 4.60 | CX LogP: 3.60 | CX LogD: 3.60 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.34 | Np Likeness Score: -0.83 |
1. Wang SP, Li Y, Huang SH, Wu SQ, Gao LL, Sun Q, Lin QW, Huang L, Meng LQ, Zou Y, Zhu QH, Xu YG.. (2021) Discovery of Potent and Novel Dual PARP/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer., 64 (23.0): [PMID:34813314] [10.1021/acs.jmedchem.1c01535] |
Source(1):